To:
(Enter e-mail address of recipient)
From:
(Enter your e-mail address)
Subject:
Comments:
(Customise the e-mail with your own comments)
  Phenoxodiol clinical advances have leapfrogged the MEI prospectus.
Novogen has today announced that due to delays in hearing its case and the significant development progress made with it...